help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernandez-Mejia, C.
Right arrow Articles by German, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandez-Mejia, C.
Right arrow Articles by German, M. S.
Endocrinology Vol. 142, No. 4 1448-1452
Copyright © 2001 by The Endocrine Society


ARTICLES

Cyclic Adenosine 3',5'-Monophosphate Increases Pancreatic Glucokinase Activity and Gene Expression1

Cristina Fernandez-Mejia, Jesus Vega-Allende, Alberto Rojas-Ochoa, Mauricio Rodriguez-Dorantes, Guillermo Romero-Navarro, Franz M. Matschinsky, Juehu Wang and Michael S. German

Nutritional Genetics Unit (C.F.M., J.V., A.R.O.), Biomedical Research Institute, National University of México, and School of Chemistry, National University of Mexico (M.R.D.), México City, C.P. 04530, México; School of Chemical-Biological Sciences (G.R.N.), Autonomous University of Sinaloa, Culiacán, Sinaloa, C.P. 80000, México; Hormone Research Institute, University of California (M.S.G., J.W.), San Francisco, California 94143-0534; and Diabetes Research Center, University of Pennsylvania Medical Center (F.M.M.), Philadelphia, Pennsylvania 19104-6015

Address all correspondence and requests for reprints to: Dr. Cristina Fernandez-Mejia, Unidad de Genetica de la Nutricion, Instituto de Investigaciones Biomedicas Universidad Nacional Autónoma de México/Instituto Nacional de Peditría, Avenue del Iman 1, Fourth Floor, México City, C.P. 04530, México. E-mail: crisfern{at}servidor.unam.mx

Comparison of the pancreatic and hepatic glucokinase gene transcripts reveals tissue-specific control of expression and the existence of two distinct promoters in a single glucokinase gene. The existence of alternate promoters suggests that separate factors regulate glucokinase transcription in the two tissues. Hepatic glucokinase expression has been shown to be repressed by cAMP; however, in the pancreatic ß-cell it is unlikely that cAMP represses glucokinase activity, as cAMP is known to positively affect glucose-induced insulin secretion, a process that in mature islets requires pancreatic glucokinase activity. In this work we demonstrate that cAMP indeed has a stimulatory effect on pancreatic glucokinase. The cyclic nucleotide stimulates pancreatic glucokinase activity after 3-h incubation, and maximal effects are observed after 6 and 12 h of treatment. Using the bDNA assay, a sensitive signal amplification technique, we detected relative increases in glucokinase messenger RNA levels of 40.5 ± 7.5% after 3-h incubation with cAMP. This stimulatory effect was increased to 106.3 ± 22% after 6-h incubation and sustained up to 12 h of incubation. Inhibition of gene transcription by actinomycin D abolishes cAMP-induced glucokinase activity. In transfected fetal islets, cAMP increased the activity of the -1000 bp rat glucokinase promoter by 60 ± 6%. These data demonstrate that cAMP has a stimulatory effect on pancreatic glucokinase gene expression and that the nucleotide has opposite effects on pancreatic and hepatic glucokinase, supporting the concept that glucokinase transcription in the liver and that in the ß-cell differ.




This article has been cited by other articles:


Home page
J EndocrinolHome page
A. J Weinhaus, L. E Stout, N. V Bhagroo, T C. Brelje, and R. L Sorenson
Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy
J. Endocrinol., June 1, 2007; 193(3): 367 - 381.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Shao, L. Qiao, and J. E. Friedman
Prolactin, progesterone, and dexamethasone coordinately and adversely regulate glucokinase and cAMP/PDE cascades in MIN6 {beta}-cells
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E304 - E310.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. M. Matschinsky
Regulation of Pancreatic {beta}-Cell Glucokinase: From Basics to Therapeutics
Diabetes, December 1, 2002; 51(90003): S394 - 404.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Rizzo, M. A. Magnuson, P. F. Drain, and D. W. Piston
A Functional Link between Glucokinase Binding to Insulin Granules and Conformational Alterations in Response to Glucose and Insulin
J. Biol. Chem., September 6, 2002; 277(37): 34168 - 34175.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H.-i. Kim, J.-Y. Cha, S.-Y. Kim, J.-w. Kim, K. J. Roh, J.-K. Seong, N. T. Lee, K.-Y. Choi, K.-S. Kim, and Y.-h. Ahn
Peroxisomal Proliferator-Activated Receptor-{gamma} Upregulates Glucokinase Gene Expression in {beta}-Cells
Diabetes, March 1, 2002; 51(3): 676 - 685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society